Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-07-04

Clinical Trial Update: Effects of Intralipid Versus Olive Oil Infusions on Endothelial Function, Immune Function, Inflammatory Markers [Phase 2, Phase 3]

View source ↗

Summary

Emory University-sponsored Phase 2/3 trial evaluating intralipid versus olive oil lipid infusions, intended to assess endothelial function, immune response, and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intralipid (intravenous lipid emulsion)
  • Olive oil infusion (olive oil lipid emulsion)

Snippet

Sponsor: Emory University | Conditions: Diabetes, Hypertension | Phase 2, Phase 3 | Status: WITHDRAWN